Splashy Product Drop or Silent Launch? Here’s How to Find the Sweet Spot
There’s no requirement to have a buzzy, PR-filled product launch. Sometimes, a quieter approach can ultimately have the biggest impact.
AI agents are not your “coworkers”
This story originally appeared in The Algorithm, our weekly newsletter on AI. To get stories like this in your inbox first, sign up here. Imagine coming in to work to learn that a new underling will report to you. The worker is not a person but an AI tool—one that your company nonetheless calls Alex, an…
Why it’s time to reset our expectations for AI
Can I ask you a question: How do you feel about AI right now? Are you still excited? When you hear that OpenAI or Google just dropped a new model, do you still get that buzz? Or has the shine come off it, maybe just a teeny bit? Come on, you can be honest with…
Nuclear startup Last Energy raises $100M for its steel-encased micro reactor
Last Energy will use the funds to build its 5 megawatt pilot reactor in Texas, which it hopes to turn on next year.
Everbloom built an AI to turn chicken feathers into cashmere
Everbloom has also developed a chemical process to transform waste fibers and feathers into upcycled materials that resemble everything from polyester to cashmere.
Solo VC and Lovable investor Neil Murray raises third Nordic-focused fund
The Nordic Web closes $6M Fund III.
Quantum navigation could solve the military’s GPS jamming problem
In late September, a Spanish military plane carrying the country’s defense minister to a base in Lithuania was reportedly the subject of a kind of attack—not by a rocket or anti-aircraft rounds, but by radio transmissions that jammed its GPS system. The flight landed safely, but it was one of thousands that have been affected…
VCs discuss why most consumer AI startups still lack staying power
The next consumer tech revolution may require an introduction of a new personal device.
OpenAI-backed biotech firm Chai Discovery raises $130M Series B at $1.3B valuation
Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could be reprogramed for cures.
I hate that I love Riverside’s AI-driven “Rewind” for podcasters
Riverside’s year-end review is amusing, but it represents a creative culture that’s increasingly entwined with AI.
Disney’s OpenAI deal is exclusive for just one year — then it’s open season
After the one year is up, Disney is free to sign similar deals with other AI companies.